Fulgent Genetics (FLGT) Net Income towards Common Stockholders (QoQ) (2015 - 2026)
Powered by 
Analysis
Fulgent Genetics (FLGT) Net Income towards Common Stockholders (QoQ) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn |
| 10 | Fulgent Genetics | 596.80 Mn | 334.14 Mn | 25.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -18.95% |
| Mar 31, 2026 | -6.01% |
| Dec 31, 2025 | -254.39% |
| Sep 30, 2025 | 65.14% |
| Jun 30, 2025 | -64.41% |
| Mar 31, 2025 | -95.82% |
| Dec 31, 2024 | 59.80% |
| Sep 30, 2024 | -68.17% |
| Jun 30, 2024 | 35.30% |
| Mar 31, 2024 | 89.50% |
| Dec 31, 2023 | -877.71% |
| Sep 30, 2023 | -16.72% |
| Jun 30, 2023 | 26.80% |
| Mar 31, 2023 | 36.29% |
| Dec 31, 2022 | -1,892.70% |
| Sep 30, 2022 | -87.85% |
| Jun 30, 2022 | -92.80% |
| Mar 31, 2022 | 48.11% |
| Dec 31, 2021 | -15.17% |
| Sep 30, 2021 | 61.01% |